Cited by 184DNA and Nucleic Acid ChemistryGlioma Diagnosis and TreatmentDNA Repair Mechanisms

G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma

Open access
Wang, Yuxiang, Yang, Jie, Wild, Aaron T., Wu, Wei H., Shah, Rachna, Danussi, Carla, Riggins, Gregory J., Kannan, Kasthuri +3 more·2019·Nature Communications

Published version of a preprint

Abstract

Mutational inactivation of ATRX (α-thalassemia mental retardation X-linked) represents a defining molecular alteration in large subsets of malignant glioma. Yet the pathogenic consequences of ATRX deficiency remain unclear, as do tractable mechanisms for its therapeutic targeting. Here we report that ATRX loss in isogenic glioma model systems induces replication stress and DNA damage by way of G-quadruplex (G4) DNA secondary structure. Moreover, these effects are associated with the acquisition of disease-relevant copy number alterations over time. We then demonstrate, both in vitro and in vivo, that ATRX deficiency selectively enhances DNA damage and cell death following chemical G4 stabilization. Finally, we show that G4 stabilization synergizes with other DNA-damaging therapies, including ionizing radiation, in the ATRX-deficient context. Our findings reveal novel pathogenic mechanisms driven by ATRX deficiency in glioma, while also pointing to tangible strategies for drug development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-08905-8

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Deregulated G4 formation is a major driver of genomic instability.

    “there is strong evidence that deregulated G4-formation is a major driver of genomic instability”

    From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [36]

    The Introduction reports that ATRX loss increased G4 formation, replication stress, and DNA damage in astrocyte and glioma stem-cell models. The Discussion links G4-mediated damage to genomic alterations in ATRX-deficient glioma, but says G4s contribute “at least in part”; it does not establish deregulated G4 formation as a major driver of genomic instability generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

10 of the 90 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [61]Sonoda Y Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma Cancer Res. 2001 61 4956 4960 11431323

Cited by

Sorted by citations

Authors
Wang, Y., Yang, J., Wild, A. T., Wu, W. H., Shah, R., Danussi, C., Riggins, G. J., Kannan, K., Sulman, E. P., Chan, T. A., & Huse, J. T.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Johns Hopkins University (US)
  • New York University (US)
Corresponding author
Huse, Jason T.
Venue
Nature Communications
Published
2019-02-26
Volume
10
Issue
1
Pages
943-943
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2950531883
Cited by
184
References
90
Citations by year
2026: 11 · 2025: 16 · 2024: 21 · 2023: 24 · 2022: 34 · 2021: 35 · 2020: 31 · 2019: 11 · 2018: 1
FWCI
9.18
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Cancer Society (RSG-16-179-01- DMC)
  • Sontag Foundation
  • Memorial Sloan-Kettering Cancer Center (P30-CA08748)
  • Sidney Kimmel Foundation
  • Cycle for Survival
  • National Institutes of Health (CA- 016672, CA08748)
  • National Cancer Institute (CA 016672, P30-CA-08748, CA08748, P30CA008748, P30CA016672)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
high-grade glioma, G-quadruplex, genomic instability, replication stress, DNA damage, copy number alterations, G-quadruplex stabilization, ionizing radiation, combination therapy, therapeutic targeting
MeSH terms
X-linked Nuclear Protein, Animals, Brain Neoplasms, DNA Damage, DNA Replication, DNA, Neoplasm, Glioma, Humans, Mice, Nude, Mutation, Genomic Instability, Cell Line, Tumor, Mice, G-Quadruplexes, Gene Knockdown Techniques, DNA Copy Number Variations, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review